Effect of arsenic trioxide on Epstein-Barr virus latent membrane protein 1-mediated E-cadherin silencing in nasopharyngeal carcinoma

Head and Neck Oncology

Volumn 4, Issue 2, 2012, Pages

  Du, C ^a   Yang, P ^a   Zhang, G ^a   Hong, C ^a   Chen, J ^a   Dong, X ^b  

^a CANCER HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ARSENIC TRIOXIDE; DNA; LATENT MEMBRANE PROTEIN 1; MESSENGER RNA; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; E CADHERIN GENE; GENE EXPRESSION REGULATION; GENE SILENCING; METASTASIS INHIBITION; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84872707988     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell. 1985 Dec;43(3 Pt 2):831-40.
2. Fahraeus R, Rymo L, Rhim JS and Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature. 1990 May;345(6274):447-9.
3. Zhao Y, Wang Y, Zeng S, Hu X. LMP1 expression is positively associated with metastasis of nasopharyngeal carcinoma: evidence from a meta-analysis. J Clin Pathol. 2012 Jan;65(1):41-5.
4. Kim KR, Yoshizaki T, Miyamori H, Hasegawa K, Horikawa T, Furukawa M, et al. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene. 2000 Mar;19(14):1764-71. (Pubitemid 30200982)
5. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991 Mar;251(5000):1451-5. (Pubitemid 121000430)
6. Tsai CN, Tsai CL, Tse KP, Chang HY, Chang YS. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci U S A. 2002 Jul;99(15):10084-9.
7. Zheng Z, Pan J, Chu B, Wong YC, Cheung AL, Tsao SW. Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum Pathol. 1999 Apr;30(4):458-66. (Pubitemid 29177827)
8. Tsai CL, Li HP, Lu YJ, Hsueh C, Liang Y, Chen CL, et al. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res. 2006 Dec;66(24):11668-76. (Pubitemid 46094178)
9. Lazo G, Kantarjian H, Estey E, Thomas D, O'Brien S, Cortes J. Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience. Cancer. 2003 May;97(9):2218-24. (Pubitemid 36444063)
10. Murgo AJ. Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development Studies. Oncologist. 2001;6 Suppl 2:22-8. (Pubitemid 32405846)
11. Du C, Wen B, Li D, Lin Y, Zheng Y, Peng X, et al. Downregulation of Epstein-Barr virus-encoded latent membrane protein-1 by arsenic trioxide in nasopharyngeal carcinoma cells. Tumori. 2006 Mar-Apr;92(2):140-8. (Pubitemid 43835974)
12. Li D, Du C, Lin Y, Wu M. Inhibition of growth of human nasopharyngeal cancer xenografts in SCID mice by arsenic trioxide. Tumori. 2002 Nov-Dec;88(6):522-6. (Pubitemid 36193904)
13. Du C, Li D, Lin Y, Wu M. Differentiation of human nasopharyngeal carcinoma xenografts and repression of telomerase activity induced by arsenic trioxide. Natl Med J India. 2004 Mar-Apr;17(2):67-70. (Pubitemid 38578962)
14. Arai M, Imazeki F, Sakai Y, Mikata R, Tada M, Seki N, et al. Analysis of the methylation status of genes upregulated by the demethylating agent, 5-aza-2'-deoxycytidine, in esophageal squamous cell carcinoma. Oncol Rep. 2008 Aug;20(2):405-12.
15. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003 Nov;349(21):2042-54. (Pubitemid 37448928)
16. Behrens J, Löwrick O, Klein-Hitpass L, Birchmeier W. The E-cadherin promoter: functional analysis of a G.Crich region and an epithelial cellspecific palindromic regulatory element. Proc Natl Acad Sci U S A. 1991 Dec;88(24):11495-9. (Pubitemid 21916068)
17. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci U S A. 1997 Sep;94(20):10907-12. (Pubitemid 27430834)
18. Cui X, Wakai T, Shirai Y, Hatakeyama K, Hirano S. Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells. Hum Pathol. 2006 Mar;37(3):298-311. (Pubitemid 43277518)
19. Huang YC, Hung WC, Chen WT, Yu HS, Chai CY. Sodium arsenite-induced DAPK promoter hypermethylation and autophagy via ERK1/2 phosphorylation in human uroepithelial cells. Chem Biol Interact. 2009 Oct;181(2):254-62.